\u963f\u65af\u5229\u5eb7AstraZeneca\uff08NASDAQ:AZN\uff09<\/a>\u548c\u5409\u5229\u5fb7\u79d1\u5b66Gilead Sciences\uff08NASDAQ:GILD\uff09\u5728\u5185\u7684\u5f88\u591a\u5236\u836f\u5546\u6b64\u524d\u5c31\u66fe\u60f3\u5403\u8fd9\u5757\u80a5\u8089\uff0c\u4f46\u6700\u7ec8\u90fd\u5012\u5728\u4e86\u540e\u671f\u4e34\u5e8a\u8bd5\u9a8c\u6216\u4e0a\u5e02\u5ba1\u6279\u9636\u6bb5\u3002\u4e0d\u8fc7\uff0c\u8fd9\u5e76\u6ca1\u6709\u963b\u6b62\u5236\u836f\u5546\u53bb\u5f00\u62d3\u8fd9\u7247\u84dd\u6d77\uff0c\u4e00\u5927\u6279\u4e09\u671f\u8bd5\u9a8c\u4ee5\u53ca\u5176\u4ed6\u66f4\u65e9\u671f\u7684\u7814\u7a76\u8fd8\u5728\u706b\u70ed\u8fdb\u884c\u4e2d\u3002\u7ec8\u6709\u4e00\u65e5\uff0c\u4f1a\u6709\u4eba\u62b5\u8fbe\u7ec8\u70b9\u7ebf\u3002<\/p>\n\u4eca\u5929\u6211\u4eec\u5c31\u6765\u8bf4\u8bf4NASH\u836f\u7269\u7684\u5e02\u573a\u524d\u666f\uff0c\u4ee5\u53ca\u8fd9\u4e2a\u8d5b\u9053\u4e0a\u7684\u73a9\u5bb6\u548c\u53ef\u80fd\u7684\u8d62\u5bb6\u3002<\/p>\n
NASH\u5e02\u573a\u7b80\u4ecb<\/h2>\n
\u7f8e\u56fdNASH\u60a3\u8005\u4eba\u6570\u7ea6\u4e3a3500\u4e07\uff0c\u800c\u5728\u5168\u7403\u8303\u56f4\u5185\uff0c37%\u7684\u4eba\u6709\u53ef\u80fd\u6700\u7ec8\u60a3\u4e0aNASH\u3002clinicaltrials.gov\u7684\u6570\u636e\u663e\u793a\uff0c\u81f3\u5c11\u6709102\u4e2a\u6b63\u5728\u8fdb\u884c\u6216\u5373\u5c06\u542f\u52a8\u7684NASH\u8bd5\u9a8c\u5904\u4e8e\u4e8c\u671f\u6216\u4e09\u671f\uff0c\u662f\u76ee\u524d\u836f\u7269\u5f00\u53d1\u6700\u70ed\u7684\u4e00\u4e2a\u9886\u57df\u3002<\/p>\n
\u6709\u5173\u8fd9\u4e2a\u5e02\u573a\u7684\u4f53\u91cf\uff0c\u5404\u5927\u673a\u6784\u7684\u9884\u6d4b\u4e0d\u4e00\u3002\u6309\u7167Insight Partners\u7684\u9884\u6d4b\uff0c\u52302028\u5e74\uff0cNASH\u836f\u7269\u5e02\u573a\u7684\u89c4\u6a21\u6216\u5c06\u8d85\u8fc7240\u4ebf\u7f8e\u5143\u3002Research and Markets\u9884\u6d4b\u52302029\u5e74\uff0c\u8be5\u5e02\u573a\u6bcf\u5e74\u7684\u4ef7\u503c\u81f3\u5c11\u5728840\u4ebf\u7f8e\u5143\uff0c\u53e6\u5916\u8fd8\u6709\u4eba\u5c06\u8fd9\u4e00\u9884\u6d4b\u6570\u5b57\u76f4\u63a5\u62c9\u5230\u4e86\u8d85\u8fc71000\u4ebf\u7f8e\u5143\uff08\u52302030\u5e74\uff09\u3002<\/p>\n
\u5373\u4f7f\u6309\u7167\u6700\u4f4e\u7684\u4f30\u7b97\u6570\u5b57\uff0c\u8fd9\u4e2a\u5e02\u573a\u4e5f\u5bb9\u7eb3\u5f97\u4e0b\u591a\u5bb6\u836f\u7269\u5f00\u53d1\u5546\u5171\u5b58\u3002\u6362\u53e5\u8bdd\u8bf4\uff0c\u672a\u6765\u51e0\u5e74NASH\u8fd9\u4e2a\u8d5b\u9053\u4e0a\u5c06\u8dd1\u51fa\u591a\u4e2a\u8d62\u5bb6\uff0c\u4f53\u73b0\u5728\u6295\u8d44\u7b56\u7565\u4e0a\u5c31\u662f\u6295\u8d44\u8005\u53ef\u4ee5\u6253\u5305\u4e70\u5165\u4e00\u4e9b\u5b9e\u529b\u6700\u5f3a\u7684\u751f\u7269\u5236\u836f\u80a1\u7968\u3002<\/p>\n
\u6700\u540e\u63d0\u4e00\u53e5\uff0c\u6309\u7167\u4eca\u5e746\u6708\u5e95\u65b0\u8fbe\u6210\u7684\u547d\u540d\u5171\u8bc6\uff0cNASH\u66f4\u51c6\u786e\u7684\u540d\u79f0\u5e94\u8be5\u662f\u4ee3\u8c22\u76f8\u5173\u8102\u80aa\u6027\u809d\u708e\uff08MASH\uff09\u3002<\/p>\n
NASH\u8d5b\u9053\u4e0a\u7684\u4e3b\u8981\u7ade\u4e89\u8005\u90fd\u6709\u8c01\uff1f<\/h2>\n
\u8fd9\u4e2a\u8d5b\u9053\u5f88\u662f\u62e5\u6324\uff0c\u9996\u5148\u662f\u5927\u578b\u5236\u836f\u5546\u8bfa\u548c\u8bfa\u5fb7Novo Nordisk\uff08NYSE:NVO\uff09\u3002\u8be5\u516c\u53f8\u6cbb\u7597NASH\u7684\u7d22\u9a6c\u9c81\u80bd\uff08\u5546\u54c1\u540dOzempic\uff09\u4e09\u671f\u8bd5\u9a8c\u6b63\u5728\u8fdb\u884c\u4e2d\uff0c\u6b64\u5916\u8fd8\u6709\u4e00\u4e2a\u4e8c\u671f\u9879\u76ee\u4ee5\u53ca\u4e24\u4e2a\u5904\u4e8e\u4e00\u671f\u7684\u5019\u9009\u4ea7\u54c1\u3002\u6b64\u5916\uff0c\u8be5\u516c\u53f8\u5df2\u7ecf\u624b\u63e1\u5927\u91cf\u7c7b\u4f3cOzempic\u8fd9\u6837\u975e\u5e38\u8d5a\u94b1\u7684\u836f\u54c1\uff0c\u56e0\u6b64\u98ce\u9669\u76f8\u5bf9\u8f83\u4f4e\u3002<\/p>\n
\u53e6\u4e00\u4e2a\u4f4e\u98ce\u9669\u7684\u9009\u62e9\u662f\u793c\u6765Eli Lilly and Co\uff08NYSE:LLY\uff09\u3002\u8be5\u516c\u53f8\u6b63\u5728\u7814\u7a76\u4e24\u4e2a\u5206\u522b\u5904\u4e8e\u4e8c\u671f\u548c\u4e00\u671f\u7684\u5019\u9009\u4ea7\u54c1\uff0c\u800c\u65e0\u8bba\u6210\u529f\u4e0e\u5426\uff0c\u5b83\u4e5f\u65e0\u9700\u62c5\u5fc3\u8d44\u91d1\u95ee\u9898\uff0c\u56e0\u4e3a\u8be5\u5236\u836f\u5546\u624b\u91cc\u4e5f\u6709\u5927\u91cf\u4e0a\u5e02\u836f\u54c1\u30022018\u5e74\uff0c\u8be5\u516c\u53f8\u5c063\u4e2a\u5728\u7814\u836f\u7269\u8d44\u4ea7\u51fa\u552e\u7ed9\u5c0f\u578b\u751f\u7269\u79d1\u6280\u516c\u53f8Terns Pharmaceuticals Inc\uff08NASDAQ:TERN\uff09\uff0c\u4e00\u98792b\/3\u671f\u8bd5\u9a8c\u9884\u8ba1\u5c06\u57282024\u5e74\u542f\u52a8\u3002<\/p>\n
\u7b2c\u4e09\u5bb6\u5f00\u53d1NASH\u7597\u6cd5\u7684\u540e\u671f\u751f\u7269\u79d1\u6280\u516c\u53f8\u662fViking Therapeutics Inc\uff08NASDAQ:VKTX\uff09\uff0c\u8be5\u516c\u53f8\u6b63\u5728\u8fdb\u884c\u4e00\u98792b\u671f\u7684\u7814\u53d1\u9879\u76ee\u3002<\/p>\n
\u4e0d\u8fc7\uff0c\u8ddd\u79bbNASH\u836f\u7269\u83b7\u6279\u4e0a\u5e02\u6700\u8fd1\u7684\u5236\u836f\u5546\u662fMadrigal Pharmaceuticals Inc\uff08NASDAQ:MDGL\uff09\u30027\u670817\u65e5\uff0c\u8be5\u516c\u53f8\u5ba3\u5e03\u5df2\u5411\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7ba1\u5c40\uff08FDA\uff09\u63d0\u4ea4\u4e86\u5019\u9009\u4ea7\u54c1\u7684\u4e0a\u5e02\u7533\u8bf7\u3002\u5982\u679c\u83b7\u6279\uff0c\u8fd9\u5c06\u662f\u7b2c\u4e00\u6b3e\u4e0a\u5e02\u7684NASH\u836f\u7269\u3002\u4f46\u5982\u679c\u88ab\u5426\u51b3\uff0cMadrigal\u80a1\u4ef7\u5c06\u906d\u9047\u6bc1\u706d\u6027\u6253\u51fb\u3002\u56e0\u6b64\uff0c\u5982\u679c\u4f60\u65e0\u6cd5\u627f\u53d7\u8fd9\u4e00\u98ce\u9669\uff0c\u73b0\u5728\u4e0d\u8981\u7740\u6025\u4e70\u5165\u3002<\/p>\n
\u5982\u679c\u4f60\u60f3\u6295\u8d44NASH\u8fd9\u4e2a\u65b0\u5174\u7684\u5e02\u573a\uff0c\u8bb0\u4f4f\u4e00\u70b9\uff0c\u751f\u7269\u79d1\u6280\u80a1\u7968\u7684\u98ce\u9669\u8981\u9ad8\u4e8e\u5927\u578b\u5236\u836f\u5546\u3002\u8003\u8651\u5230NASH\u836f\u7269\u7684\u7814\u53d1\u96be\u5ea6\uff0c\u6211\u4eec\u8981\u5bf9\u5019\u9009\u4ea7\u54c1\u6700\u7ec8\u5931\u8d25\u505a\u597d\u5fc3\u7406\u51c6\u5907\uff0c\u540c\u65f6\u505a\u597d\u6295\u8d44\u7684\u591a\u5143\u5316\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u672a\u6765\u51e0\u5e74\uff0cNASH\u836f\u7269\u7814\u53d1\u9884\u8ba1\u5c06\u6210\u4e3a\u4e00\u5927\u70ed\u95e8 \u6309\u7167\u6709\u4e9b\u4f30\u7b97\uff0c\u867d\u7136\u73b0\u5728\u8fd8\u6ca1\u6709\u4e0a\u5e02\u836f\u7269\uff0c\u4f46\u975e\u9152\u7cbe\u6027\u8102\u80aa\u6027\u809d\u708e\uff08NA […]<\/p>\n","protected":false},"author":27,"featured_media":425562,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,747,925,1997],"class_list":["post-470449","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-747","tag-925","tag-1997","sectors-life-science-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/470449","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=470449"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/470449\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/425562"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=470449"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=470449"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=470449"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}